REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies
Clinical trial NCT03435640 · TERMINATED
Trial details
- NCT number
- NCT03435640
- Sponsor
- Nektar Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2022-05-09
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.